Modig Berndt 4

What Happened

• Berndt Modig, CEO of Pharvaris N.V. (PHVS), sold 2,292 shares on 2026-05-18 in an open-market/private sale. The filing reports a weighted average sale price of $29.22, for proceeds of $66,977. This sale was executed under a Rule 10b5-1 trading plan and included shares that were acquired upon vesting of restricted stock units.

Key Details

• Transaction date: 2026-05-18; Form 4 filed: 2026-05-20 (filed within the typical 2-business-day window).
• Reported weighted average price: $29.22; reported total proceeds: $66,977.
• Footnote: Sales were pursuant to a Rule 10b5-1 plan; sale prices for the individual transactions ranged from $29.47 to $30.40. The filing notes the reporting person can provide the number of shares sold at each separate price on request.
• Shares owned after the transaction: not specified in the information provided in this summary.

Context

• Sales under a Rule 10b5-1 plan are prearranged and often scheduled in advance, which can mean they are routine rather than a realtime signal about the insider’s view of the company. This filing reports a sale (not a purchase), which reduces insider holdings but, by itself, does not prove a change in sentiment.